Ignite Creation Date:
2024-05-06 @ 1:05 AM
Last Modification Date:
2024-10-26 @ 10:58 AM
Study NCT ID:
NCT01724554
Status:
COMPLETED
Last Update Posted:
2015-05-22
First Post:
2012-11-07
Brief Title:
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
Sponsor:
Ophthalmic Consultants of Boston
Organization:
Ophthalmic Consultants of Boston
Study Overview
Official Title:
A Single-center Open-label Study Evaluating the Impact of Repeat Intravitreal Injections of Aflibercept on Capillary Non-Perfusion CNP in Subjects With Proliferative Retinopathy andor Macular Edema Secondary to Proliferative Diabetic Retinopathy and Central Retinal Venous Occlusive Disease
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ANDROID
Brief Summary:
The purpose of this study is to look at how effective safe and well tolerated Intravitreal Aflibercept Injection is in subjects with Central Retinal Vein Occlusion CRVO or Proliferative Diabetic Retinopathy PDR
Detailed Description:
Protocol available upon request
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None